California Institute of Regenerative Medicine and Cancer Research: A promise broken?

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Approximately 21 years ago, I had the privilege of working and helping to pass Proposition 71, which authorized $3 billion dollars in state bonds to fund stem cell research in California. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Stephen J. Forman, MD
Director, Hematologic Malignancies Research Institute, Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratory, Co-director, Hematologic Malignancies Program, City of Hope Comprehensive Cancer Center; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope
Table of Contents

YOU MAY BE INTERESTED IN

Marlon L. Wong, associate professor of clinical physical therapy at the University of Miami Miller School of Medicine, was awarded a grant from Gabrielle’s Angel Foundation for Cancer Research. The three-year, $225,000 award will support research focused on improving quality of life for patients living with chemotherapy-induced peripheral neuropathy and other long-term effects of cancer treatment.
Stephen J. Forman, MD
Director, Hematologic Malignancies Research Institute, Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratory, Co-director, Hematologic Malignancies Program, City of Hope Comprehensive Cancer Center; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login